Detalles de la búsqueda
1.
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
N Engl J Med
; 378(15): 1408-1418, 2018 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29420164
2.
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer.
N Engl J Med
; 377(4): 352-360, 2017 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28578607
3.
Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial.
Invest New Drugs
; 36(3): 476-486, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29177975
4.
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study.
Lancet Oncol
; 16(2): 152-60, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25601341
5.
A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older.
Blood
; 114(6): 1166-73, 2009 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-19470696
6.
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy.
Breast Cancer Res Treat
; 110(2): 327-35, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17851757
7.
Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer.
Clin Pharmacokinet
; 56(1): 55-63, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27324190
8.
Correlation between Prostate-Specific Antigen Kinetics and Overall Survival in Abiraterone Acetate-Treated Castration-Resistant Prostate Cancer Patients.
Clin Cancer Res
; 21(14): 3170-7, 2015 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25829400
9.
Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302).
Eur Urol
; 66(5): 815-25, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24647231
10.
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis.
Eur J Cancer
; 48(15): 2361-8, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22541893
11.
Trabectedin has a low cardiac risk profile: a comprehensive cardiac safety analysis.
Cancer Chemother Pharmacol
; 68(5): 1223-31, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21416137
12.
Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules.
J Clin Oncol
; 27(25): 4188-96, 2009 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19652065
Resultados
1 -
12
de 12
1
Próxima >
>>